Serum

'Good News' Around Coronavirus Vaccine Expected Soon, Says Serum Institute CEO Adar Poonawalla

Union Health Minister Launches India’s First Indigenous Pneumonia Vaccine By SII

Good News For India As Oxford Covid-19 Vaccine Likely To Become First To Get Nod For Emergency Use

Covid-19 Vaccine: 'Frivolous Claims Cause Skepticism,' SII CEO Proposes That Govt Protect Manufacturers

EXPLAINED | How To Register For Covid-19 Vaccine In India With Govt's Co-WIN App

Health Ministry Denies Reports Of Rejection Of SII, Bharat Biotech Emergency Use Authorisation

SII Corona Vaccine Cost: Serum Institute Getting Closer To Signing Deal, Likely To Sell A Dose For Rs 250

Bharat Biotech Applies For Emergency Authorization Of 'Covaxin', Becomes Second Indian Company To Seek Approval

Corona Vaccine: Serum Institute Becomes First Indian Pharma To Seek Nod For Emergency Use Of Oxford Vaccine In India

PM Modi To Hold An All Party Meet On Dec 4 For Covid-19 Vaccine Roadmap

'Applying For Emergency Use Of Covid Vaccine In 2 Weeks', Says Serum Institute's Adar Poonawalla After PM Modi's Visit

Narendra Modi Pune Visit HIGHLIGHTS: After PM's Visit, SII CEO Says In Process Of Getting Emergency License For Vaccine